0001209191-20-048298.txt : 20200825 0001209191-20-048298.hdr.sgml : 20200825 20200825190617 ACCESSION NUMBER: 0001209191-20-048298 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200824 FILED AS OF DATE: 20200825 DATE AS OF CHANGE: 20200825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shameze Rampertab CENTRAL INDEX KEY: 0001721810 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 201133826 MAIL ADDRESS: STREET 1: C/O ZOMEDICA PHARMACEUTICALS CORP. STREET 2: 3928 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX, INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX INC. DATE OF NAME CHANGE: 20131210 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-24 0 0000876378 TRANSENTERIX, INC. TRXC 0001721810 Shameze Rampertab 635 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 0 1 0 0 EVP, Chief Financial Officer Stock Option 0.42 2020-08-24 4 A 0 150000 0.00 A 2027-08-24 Common Stock 150000 150000 D Restricted Stock Unit 2020-08-24 4 A 0 30000 0.00 A Common Stock 30000 30000 D Restricted Stock Unit 2020-08-24 4 A 0 20000 0.00 A Common Stock 20000 20000 D The stock options vest one-third annually on each of August 24, 2021, 2022 and 2023, as long as the Reporting Person remains in continuous service during the vesting period. Subject to acceleration of vesting in full upon consummation of a change in control of the Registrant. Each restricted stock unit represents the right to receive one share of the Registrant's common stock. Forfeiture restrictions will lapse on the restricted stock units in three equal installments of 10,000 on each of July 1, 2021, 2022 and 2023, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan and the Reporting Person's Employment Agreement with the Registrant. Represents performance-based restricted stock units with time-based vesting in three installments of 6,667, 6,667 and 6,666 on each of July 1, 2021, 2022 and 2023, and performance-based vesting only if, during the three year performance period ended August 24, 2023, the Registrant's stock price is equal to or greater than $1.00 for twenty consecutive trading days. /s/ Joshua Weingard, as attorney-in-fact for Shameze Rampertab 2020-08-25